12/24
06:15 am
ivvd
Invivyd (NASDAQ:IVVD) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
Invivyd (NASDAQ:IVVD) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
12/23
08:12 am
ivvd
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
Medium
Report
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
12/23
08:12 am
ivvd
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
Medium
Report
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID [Yahoo! Finance]
12/23
07:05 am
ivvd
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Medium
Report
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
12/23
07:01 am
ivvd
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Low
Report
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
12/23
05:31 am
ivvd
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion [Yahoo! Finance]
Low
Report
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion [Yahoo! Finance]
12/22
06:01 am
ivvd
Invivyd (NASDAQ:IVVD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
High
Report
Invivyd (NASDAQ:IVVD) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
12/19
01:33 am
ivvd
How Recent Clinical Progress Is Rewriting the Story for Invivyd [Yahoo! Finance]
Low
Report
How Recent Clinical Progress Is Rewriting the Story for Invivyd [Yahoo! Finance]
12/16
04:38 pm
ivvd
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/30
12:41 am
ivvd
A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development [Yahoo! Finance]
Low
Report
A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development [Yahoo! Finance]
11/27
02:49 pm
ivvd
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
06:43 am
ivvd
Invivyd (NASDAQ:IVVD) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
Low
Report
Invivyd (NASDAQ:IVVD) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
11/25
08:07 am
ivvd
Invivyd (NASDAQ:IVVD) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Medium
Report
Invivyd (NASDAQ:IVVD) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
11/25
08:01 am
ivvd
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/25
07:01 am
ivvd
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
Medium
Report
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
11/24
07:01 am
ivvd
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
Medium
Report
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
11/19
02:48 am
ivvd
Invivyd: Why I'm Selling The CDTX Read-Through Rally [Seeking Alpha]
Low
Report
Invivyd: Why I'm Selling The CDTX Read-Through Rally [Seeking Alpha]
11/18
03:51 pm
ivvd
Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination [Seeking Alpha]
Low
Report
Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination [Seeking Alpha]
11/17
11:50 pm
ivvd
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Low
Report
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/17
10:40 pm
ivvd
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
Low
Report
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
11/17
04:41 pm
ivvd
Invivyd Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
Low
Report
Invivyd Announces Proposed Public Offering of Common Stock [Yahoo! Finance]
11/17
04:01 pm
ivvd
Invivyd Announces Proposed Public Offering of Common Stock
Medium
Report
Invivyd Announces Proposed Public Offering of Common Stock
11/16
09:36 pm
ivvd
Invivyd (IVVD) Is Up 48.3% After Strong Q3 Financials and FDA Trial Clearance for VYD2311 – Has the Bull Case Changed? [Yahoo! Finance]
High
Report
Invivyd (IVVD) Is Up 48.3% After Strong Q3 Financials and FDA Trial Clearance for VYD2311 – Has the Bull Case Changed? [Yahoo! Finance]
11/15
10:33 am
ivvd
Invivyd (NASDAQ:IVVD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
High
Report
Invivyd (NASDAQ:IVVD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/15
05:41 am
ivvd
Invivyd (IVVD) Valuation in Focus After Strong Q3 Revenue Growth and Smaller Net Loss [Yahoo! Finance]
High
Report
Invivyd (IVVD) Valuation in Focus After Strong Q3 Revenue Growth and Smaller Net Loss [Yahoo! Finance]